MedTherapy Biotechnology was incorporated in 2018 by a group of globally renowned cancer gene therapy researchers and industry experts, with a mission to make cancer gene therapy accessible and affordable for all cancer patients in the US and throughout the world, especially in developing countries. MedTherapy Biotechnology (India) Pvt. Ltd. was incorporated in the year 2020 as a fully owned subsidiary of MedTherapy Biotechnology Inc., USA with the objective of making it a Global manufacturing centre of Cell and Gene Therapy to offer affordable CGT products and services in India and worldwide.